CL
OTC · CLCS
Cell Source, Inc.
Healthcare · Biotechnology
$0.60
Down-$0.01 (-0.88%)
Updated Aug 16, 2026, 3:48 AM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 18.02M
- P/E ratio
- -5.15
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 5.2K
- Avg. volume
- 4.21K
Price performance
CLCS price history
1M range · 0 trading sessions · Daily adjusted prices
CLCS does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest CLCS news
The latest Smart Investors Daily articles mentioning CLCS.
Stock researchCompany · Overview
CLCS research
Overview
Company profile and research snapshot.
Company profile
CELL SOURCE INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
